Urinary metabolites indicative of Hypoxen administration monitored by LC–HRMS/MS
Laboratory analysis · 2025
- What was studied
- Exploratory post-administration urine analysis
- Main finding
- The analytical study identified eight plausible Hypoxen-related urinary analytes. It provides markers for detecting administration, not evidence of improved endurance or clinical effectiveness.
Study data at a glance
- Participants or experimental model
- Exploratory post-administration urine analysis
- Reported results
- The analytical study identified eight plausible Hypoxen-related urinary analytes. It provides markers for detecting administration, not evidence of improved endurance or clinical effectiveness.
Study limitations and source details
Study limitations
- Tentative metabolite assignments and exploratory sampling limit interpretation.
- Detection of use is distinct from proof of efficacy, safety or a doping-rule violation.
Source details
Journal article
Publisher analytical report reviewed; chemical assignments are reported at the authors’ stated certainty.
Publisher methods and results reviewed
Sources checked
Citation
C. Görgens, T. Möller, S. Guddat, and colleagues. Urinary metabolites indicative of Hypoxen administration monitored by LC–HRMS/MS Drug Testing and Analysis. 17(2):225–230; first published online 23 April 2024
Study source ↗ · DOI 10.1002/dta.3701 · Bibliography entry · Link to this summary